13th World ADC London 2023
Evvnt Promotion / evvnt
Archive
13.03.2023 - 16.03.2023 ExCeL London, 1 Western Gateway, E16 1XL London, United Kingdom
Time: 8:00 am to 4:00 pm
Conference themes
The 13th World ADC London returns in 2023 as Europe's longest standing and definitive antibody-drug conjugate event - and it's back bigger and better than before!
With the recent approvals of ImmunoGen's ELAHERE, Astrazeneca and Daiichi Sankyo's DESTINY-Breast04, supporting Enhertu's use in HER2-low breast cancer as a new therapeutically targetable category, the ADC space has continued to make major waves throughout 2022, a joy to see for oncology patients around the world.
The 13th World ADC London returns in 2023 as Europe's longest standing and definitive antibody-drug conjugate event - and it's back bigger and better than before!
With the recent approvals of ImmunoGen's ELAHERE, Astrazeneca and Daiichi Sankyo's DESTINY-Breast04, supporting Enhertu's use in HER2-low breast cancer as a new therapeutically targetable category, the ADC space has continued to make major waves throughout 2022, a joy to see for oncology patients around the world.
Scientific Society
Hanson Wade
Hanson Wade
Notes
Brochure: https://go.evvnt.com/1452270-3?pid=4832
Speakers: Aarti Jashnani, Principal Scientist, Bristol Myers Squibb, Abderrahman Laadem, Vice President, Global Head, Early Clinical Development, Daiichi Sankyo and more
Brochure: https://go.evvnt.com/1452270-3?pid=4832
Speakers: Aarti Jashnani, Principal Scientist, Bristol Myers Squibb, Abderrahman Laadem, Vice President, Global Head, Early Clinical Development, Daiichi Sankyo and more
Enquiries and Registration:
https://go.evvnt.com/1452270-2?pid=4832
Ms. Jessica Durston
Health Services, Public Health
Languages
English
English
Congress fees
GBP 2099.00 - GBP 5195.00
GBP 2099.00 - GBP 5195.00
Participants expected
1000
1000
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
